GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine

Journal of Neuroscience

Volumn 16, Issue 24, 1996, Pages 8132-8139

  Cass, Wayne A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

dopamine; GDNF; in vivo electrochemistry; methamphetamine; neurotoxicity; neurotrophic factor; serotonin; striatum

Indexed keywords

DOPAMINE; METHAMPHETAMINE; NEURITE PROMOTING FACTOR; SEROTONIN;

ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ELECTROCHEMISTRY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

EID: 0029852888     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-24-08132.1996     Document Type: Article

References (53)

1. Axt KJ, Mamounas LA, Molliver ME (1994) Structural features of amphetamine neurotoxicity in the brain. In: Amphetamine and its analogs: psychopharmacology, toxicology, and abuse (Cho AK, Segal DS, eds), pp 315-367. San Diego: Academic.
2. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
3. Beck KD, Irwin I, Valverde J, Brennan TJ, Langston JW, Hefti F (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16:665-673.
4. Bittner SE, Wagner GC, Aigner TG, Seiden LS (1981) Effects of high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol Biochem Behav 14:481-486.
5. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle P, Hoffer BJ, Granholm A-CE (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 355:479-489.
6. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicily. J Pharmacol Exp Ther 268:1571-1580.
7. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
8. Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum following neurotoxic doses of methamphetamine. J Pharmacol Exp Ther, in press.
9. Cass WA, Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176:259-263.
10. Cass WA, Gerhardt GA (1995) In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-207.
11. Cass WA, Gerhardt GA, Mayfield RD, Curella P, Zahniser NR (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem 59:259-266.
12. Cass WA, Zahniser NR, Flach KA, Gerhardt GA (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61:2269-2278.
13. Dawson Jr R, Beal MF, Bondy SC, DiMonte DA, Isom GE (1995) Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol Appl Pharmacol 134:1-17.
14. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V (1996) GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-793.
15. Finnegan KT, Ricaurte G, Seiden LS, Schuster CR (1982) Altered sensitivity to D-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of D-methylamphetamine. Psychopharmacology 77:43-52.
16. Friedemann MN, Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging 13:325-332.
17. Garris PA, Wightman RM (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14:442-450.
18. Gash DM, Zhang Z, Cass WA, Ovadia A, Simmerman L, Martin D, Russell D, Collins F, Hoffer BJ, Gerhardt GA (1995) Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J Comp Neurol 363:345-358.
19. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in GDNF-treated parkinsonian monkeys. Nature 380:252-255.
20. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290:390-395.
21. Gibb JW, Hanson GR, Johnson M (1994) Neurochemical mechanisms of toxicity. In: Amphetamine and its analogs: psychopharmacology, toxicology, and abuse (Cho AK, Segal DS, eds), pp 269-295. San Diego: Academic.
22. Giovanni A, Liang LP, Hastings TG, Zigmond MJ (1995) Estimating hydroxy radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64:1819-1825.
23. Gratton A, Wise RA (1994) Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci 14:4130-4146.
24. Hall ME, Hoffer BJ, Gerhardt GA (1989) Rapid and sensitive determination of catecholamines in small tissue samples by high performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC/GC 7:258-265.
25. Hirata H, Ladenheim B, Rothman RB, Epstein C, Cadet JL (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res 677:345-347.
26. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin L-FH, Gerhardt GA (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182:107-111.
27. Hornykiewicz O (1993) Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol 60:140-147.
28. Hou J-GG, Lin L-FH, Mytilineou C (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J Neurochem 66:74-82.
29. Hudson J, Granholm A-C, Gerhardt G, Henry MA, Hoffman A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425-432.
30. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis J-C, Hu S, Altrock BW, Fox GM (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124.
31. Kearns CM, Gash DM (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672:104-111.
32. Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
33. Lorez H (1981) Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine. Life Sci 28:911-916.
34. Luthman J, Friedemann M, Bickford P, Olson L, Hoffer BJ, Gerhardt GA (1993) In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Neuroscience 52:677-687.
35. Martin D, Miller G, Fischer N, Dix D, Cullen T, Russell D (1996) Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats. Eur J Neurosci 8:1249-1255.
36. Mattson MP, Cheng B, Smith-Swintosky VL (1993) Neurotrophic factor mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism. Semin Neurosci 5:295-307.
37. Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB (1995) GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. NeuroReport 7:348-352.
38. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic.
39. Pu C, Vorhees CV (1995) Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study. Synapse 19:97-104.
40. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235:93-103.
41. Ricaurte GA, Sabol KE, Seiden LS (1994) Functional consequences of neurotoxic amphetamine exposure. In: Amphetamine and its analogs: psychopharmacology, toxicology, and abuse (Cho AK, Segal DS, eds), pp 297-313. San Diego: Academic.
42. Sauer H, Rosenblad C, Bjorklund A (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesions. Proc Natl Acad Sci USA 92:8935-8939.
43. Seiden LS, Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs. In: Psychopharmacology: the third generation of progress (Meltzer HY, ed), pp 359-366. New York: Raven.
44. Seiden LS, Fischman MW, Schuster CR (1975/76) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219.
45. Shults CW, Kimber T, Martin D (1996) Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. NeuroReport 7:627-631.
46. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
47. Suaud-Chagny MF, Dugast C, Chergui K, Msghina M, Ganon F (1995) Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. J Neurochem 65:2603-2611.
48. Tomac A, Lindqvist E, Lin L-FH, Ogren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
49. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80-83.
50. Trupp M, Arenas E, Fainzilber M, Nilsson A-S, Sieber B-A, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumäe U, Sariola H, Saarma M, Ibáñez CF (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-789.
51. Walsh SL, Wagner GC (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 263:617-626.
52. Wood ER, Coury A, Blaha CD, Phillips AG (1992) Extracellular dopamine in the rat striatum during ischemia and reperfusion as measured by in vivo electrochemistry and in vivo microdialysis. Brain Res 591:151-159.
53. Zeevalk GD, Nicklas WJ, Sonsalla PK (1994) NMDA receptor involvement in two animal models of Parkinson's disease. Neurobiol Aging 15:269-270.